Both in Diagnostics
BIOMERICA vs Insight Molecular Diagnostics
Over the past year BMRA returned −37.3% and IMDX returned −55.2%; their daily moves had a correlation of 0.10.
BMRA −37.3% IMDX −55.2%Growth of $1, one year, split-adjusted
| Metric | BMRA | IMDX |
|---|---|---|
| Price | $1.70 | $2.74 |
| Market cap | $7.8M | $89.7M |
| Today | −1.73% | −4.20% |
| 1 month | −17.1% | −25.3% |
| 6 months | −22.2% | −40.2% |
| Year to date | −32.5% | −63.5% |
| 1 year | −39.1% | −54.4% |
| Revenue growth (YoY) | −8.3% | −53.9% |
| Gross margin | 8.1% | 65.7% |
| Net margin | −97.4% | −4711.3% |
| P/E (TTM) | — | — |
| Price / sales | 1.8× | 53.7× |
| Net cash | $2.7M | $17.8M |
| Dividend yield | — | — |
| Volatility (60d) | 72.1% | 95.6% |
| Short % of float | 0.3% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).